Biohaven Ltd. (BHVN)
(Real Time Quote from BATS)
$44.55 USD
-1.39 (-3.03%)
Updated Sep 24, 2024 02:56 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Biohaven Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -408.17 | -570.28 | -848.40 | -768.62 | -528.81 |
Depreciation/Amortization & Depletion | 6.91 | 1.39 | 24.93 | 14.31 | 5.65 |
Net Change from Assets/Liabilities | 24.61 | -28.60 | -216.77 | -106.81 | 40.97 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 44.92 | 299.81 | 209.14 | 158.24 | 104.86 |
Net Cash From Operating Activities | -331.73 | -297.69 | -831.10 | -702.88 | -377.33 |
Property & Equipment | -3.05 | -6.07 | -1.72 | -3.97 | -3.78 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -35.00 | 0.00 | 0.00 | 0.00 |
Investments | 132.88 | -259.72 | 28.27 | -224.41 | 0.00 |
Other Investing Activities | 0.00 | -4.00 | 0.00 | -41.50 | 0.00 |
Net Cash from Investing Activities | 129.83 | -304.79 | 26.55 | -269.88 | -3.78 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 247.92 | 283.80 | 416.07 | 321.76 | 435.74 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 428.78 | 261.76 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -36.01 | 483.79 | 0.00 | 205.30 | -1.15 |
Net Cash from Financing Activities | 211.91 | 767.60 | 844.85 | 788.82 | 434.59 |
Effect of Exchange Rate Changes | -0.50 | 0.43 | -0.19 | 0.44 | 0.00 |
Net Change In Cash & Equivalents | 9.52 | 165.55 | 40.11 | -183.50 | 53.48 |
Cash at Beginning of Period | 242.60 | 77.06 | 134.23 | 317.73 | 264.25 |
Cash at End of Period | 252.12 | 242.60 | 174.34 | 134.23 | 317.73 |
Diluted Net EPS | -5.73 | -12.75 | -13.09 | -13.06 | -10.91 |
Fiscal Year End for Biohaven Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -499.28 | -179.50 | -408.17 | -263.41 | -160.84 |
Depreciation/Amortization & Depletion | 3.40 | 1.45 | 6.91 | 5.02 | 3.48 |
Net Change from Assets/Liabilities | 2.31 | 25.62 | 24.61 | 33.33 | 30.55 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 223.13 | 49.80 | 44.92 | 8.22 | 4.78 |
Net Cash From Operating Activities | -270.44 | -102.64 | -331.73 | -216.84 | -122.03 |
Property & Equipment | -3.39 | -0.44 | -3.05 | -2.58 | -1.33 |
Acquisition/ Disposition of Subsidiaries | 0.39 | 0.39 | 0.00 | 0.00 | 0.00 |
Investments | -60.90 | 34.08 | 132.88 | 136.32 | 76.53 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -63.90 | 34.03 | 129.83 | 133.74 | 75.20 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 318.52 | 0.00 | 247.92 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 6.03 | 3.42 | -36.01 | -33.33 | 6.33 |
Net Cash from Financing Activities | 324.55 | 3.42 | 211.91 | -33.33 | 6.33 |
Effect of Exchange Rate Changes | -0.01 | -0.01 | -0.50 | -0.19 | -0.15 |
Net Change In Cash & Equivalents | -9.80 | -65.19 | 9.52 | -116.61 | -40.65 |
Cash at Beginning of Period | 252.12 | 252.12 | 242.60 | 242.60 | 242.60 |
Cash at End of Period | 242.32 | 186.93 | 252.12 | 125.99 | 201.95 |
Diluted Net EPS | -3.64 | -2.20 | -1.88 | -1.50 | -1.32 |